AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11004058
Drug: IV lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV lidocaine (bolus 2 mg/kg, then infusion 3 mg/kg/h)
Trial: 1799915
Drug: Cefpodoxime proxetil
RxNorm normalized name: Cefpodoxime Proxetil
DrugBank: Cefpodoxime (DB01416)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefpodoxime proxetil 100 mg orally with food every 12 hours
Trial: 1799915
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V potassium 250 mg orally on an empty stomach every six hours
Trial: 22119995
Drug: Intraperitoneal (IP)
RxNorm normalized name: Intraperitoneal Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal (IP) chemotherapy
Trial: 21455089
Drug: Thoracic epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic epidural analgesia (TEA) with bupivacaine 1 mg/mL, epinephrine 2 μg/mL, and fentanyl 2 μg/mL
Trial: 22930695
Drug: Topical glyceryl
RxNorm normalized name: glyceryl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical glyceryl trinitrate (GTN) treatment
Trial: 16762763
Drug: Anticoagulant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulant treatment for acute PE
Trial: 17634183
Drug: Disodium cromoglycate
RxNorm normalized name: Disodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium cromoglycate (DSCG) 10 mg three times daily for months 1‐18
Trial: 16420563
Drug: Pro12Ala polymorphism
RxNorm normalized name: ANGELICA POLYMORPHA ROOT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pro12Ala polymorphism in the peroxisome proliferator activated-receptor gamma gene
Trial: 16420563
Drug: Thr164Ile polymorphism
RxNorm normalized name: ANGELICA POLYMORPHA ROOT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thr164Ile polymorphism in the beta-2 adrenergic receptor gene
Trial: 9409295
Drug: Cyclic oral
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic oral estradiol combined with progesterone
Trial: 26945767
Drug: Conventional perioperative
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional perioperative antibiotics plus vancomycin and gentamicin injection (twice)
Trial: 6788433
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of factor VIII (7 or 14 units per kg)
Trial: 16527796
Drug: NTI under
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NTI under CTSC guidance (G[+] group)
Trial: 18067499
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (10 mg/kg ev bolus followed by 1 mg/kg/hour perfusion)
Trial: 11707839
Drug: Methotrexate-based chemotherapy
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate-based chemotherapy
Trial: 15842446
Drug: Early discharge
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early discharge with nurse follow-up (weekly or biweekly telephone calls)
Trial: 21645895
Drug: drospirenone (DRSP)
RxNorm normalized name: Drospirenone
DrugBank: Drospirenone (DB01395)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: drospirenone (DRSP) 2 mg + E(2) 1 mg
Trial: 9732194
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg piroxicam (2 ml) administered intramuscularly 45 min before ESWL
Trial: 31957953
Drug: Low-dose TAS-205
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose TAS-205 (6.67-13.33 mg/kg/dose)
Trial: 10984252
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH)
Trial: 3955779
Drug: Cefotaxime 2g
DrugBank: Cefotaxime (DB00493)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefotaxime 2g twice daily (1st trial)
Trial: 347034
Drug: polyinosinic-polycytidylic acid
RxNorm normalized name: Polyinosinic-polycytidylic acid/inactivated rabies virus
DrugBank: YS-ON-001 (DB17291)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: polyinosinic-polycytidylic acid (rIn.rCn) at doses of 3-12 mg/kg (Lot 2)
Trial: 17497438
Drug: Azithromycin plus
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin plus Oral Hygiene Program (OHP)
Trial: 17497438
Drug: Oral Hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Hygiene Program (OHP) alone
Trial: 1743245
Drug: Oxazepam 25
RxNorm normalized name: Oxazepam 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam 25 mg/d
Trial: 31467115
Drug: Inhaled α1-antitrypsin
RxNorm normalized name: alpha 1-antitrypsin
DrugBank: Alpha-1-proteinase inhibitor (DB00058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled α1-antitrypsin (AAT)
Trial: 2414253
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy without added chemotherapy
Trial: 9105542
Drug: Gliquidone 30
RxNorm normalized name: gliquidone 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliquidone 30 mg tablet administered 15 min before breakfast
Trial: 29738877
Drug: Oral group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral group
Trial: 10344062
Drug: Captopril 6.25
RxNorm normalized name: captopril 6.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 6.25 mg
Trial: 15452681
Drug: Isradipine with
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine with high dose methamphetamine (30 mg)
Trial: 19364964
Drug: Intensive dose-dense
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive dose-dense (IDD) chemotherapy
Trial: 17587070
Drug: Amoxicillin (AMOX)
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin (AMOX) 1 g twice daily for 100 days
Trial: 22215943
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (2000 IU/d) with Peg‐α‐2b interferon (1.5 μg/kg per week) plus ribavirin (1000‐1200 mg/d)
Trial: 24237300
Drug: Interferon-alpha lozenge
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha lozenge 500 IU/day
Trial: 27215298
Drug: Free sachet
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free sachet water vouchers (15 L/week/child) plus education
Trial: 25596108
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy to the rectum
Trial: 28973220
Drug: Individualized treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized treatment group
Trial: 26535969
Drug: Extended-release hydrocodone
RxNorm normalized name: hydrocodone Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release hydrocodone (20-300mg) every 12 hours
Trial: 20673731
Drug: Closed reduction
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closed reduction and functional treatment
Trial: 12559267
Drug: No gel
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No gel injection
Trial: 9424404
Drug: House dust
RxNorm normalized name: House dust
DrugBank: House dust (DB10345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: House dust mite allergen (HDM) extract inhalation challenge in atopic asthmatics (AA)
Trial: 9424404
Drug: House dust
RxNorm normalized name: House dust
DrugBank: House dust (DB10345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: House dust mite allergen (HDM) extract inhalation challenge in atopic non-asthmatics (AN)
Trial: 8243376
Drug: Felbamate (FBM)
RxNorm normalized name: Felbamate
DrugBank: Felbamate (DB00949)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felbamate (FBM) as add-on treatment
Trial: 9081682
Drug: High-fat diet
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat diet with fish oil capsules (6 or 12 capsules daily)
Trial: 8256107
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg weekly chloroquine (n = 156)
Trial: 24632279
Drug: Drug-eluting stent
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stent (DES) treatment in patients without DM and type B2/C lesions
Trial: 9101306
Drug: ACE inhibitors
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitors (ceronapril or delapril)
Trial: 23503379
Drug: Genetic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genetic therapy combined with traditional treatment (conservative means) in 39 patients.
Trial: 22375408
Drug: Respiratory exercises
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Respiratory exercises increases Chinese medicine
Trial: 19909605
Drug: Piroxicam 10
RxNorm normalized name: piroxicam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam 10 mg oral dose 1-2 hours before embryo transfer
Trial: 29145890
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg metolazone single dose
Trial: 24806159
Drug: Letermovir 120
RxNorm normalized name: letermovir 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letermovir 120 mg per day
Trial: 16544963
Drug: 375 mg
RxNorm normalized name: niacin 375 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 375 mg bd acetazolamide
Trial: 22449319
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy plus Roux‐en‐Y gastric bypass
Trial: 12932243
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 1% pyrithione zinc shampoo and 5% minoxidil topical solution
Trial: 22449319
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy plus sleeve gastrectomy
Trial: 20861810
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of radiation therapy
Trial: 31952661
Drug: Intraperitoneal chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal chemotherapy
Trial: 19583558
Drug: Hormone treatment
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone treatment
Trial: 19287303
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone (300 microg twice weekly)
Trial: 29389170
Drug: Varenicline 1
RxNorm normalized name: varenicline 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline 1 mg/day
Trial: 12537629
Drug: Praziquantel treatment
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Praziquantel treatment
Trial: 20031704
Drug: Angiography-directed therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiography-directed therapy
Trial: 15632861
Drug: Loratidine 10
RxNorm normalized name: loratadine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratidine 10 mg daily for 7 days (group B)
Trial: 15632861
Drug: Loratidine 10
RxNorm normalized name: loratadine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratidine 10 mg daily for 7 days (group A)
Trial: 15205487
Drug: Alpha tocopherol
RxNorm normalized name: alpha tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha tocopherol (50 mg daily)
Trial: 15205487
Drug: Beta carotene
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta carotene (20 mg daily)
Trial: 24935294
Drug: mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: mycophenolate mofetil 2 g/d plus standard‐dose cyclosporine
Trial: 27189087
Drug: Tian Jiu
RxNorm normalized name: Tian Qi Root
DrugBank: Panax notoginseng root (DB14304)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tian Jiu therapy (TJ)
Trial: 27801753
Drug: Lower enteral
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower enteral protein intake (0.4 g/100 mL expressed breast milk)
Trial: 27801753
Drug: Higher enteral
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher enteral protein intake (1 g/100 mL expressed breast milk)
Trial: 10992369
Drug: Digital rectal
RxNorm normalized name: BD Thermometer Digital Rectal (obsolete)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital rectal examination
Trial: 2186980
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg at 10 pm
Trial: 2877383
Drug: Low-dose prednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prednisolone treatment
Trial: 18430965
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate 300 mg weekly for 16 weeks
Trial: 15290000
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg BID
Trial: 14505898
Drug: DTPw vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPw vaccine
Trial: 28323965
Drug: C-terminal peptide-modified
RxNorm normalized name: CCK C-terminal octapeptide
DrugBank: Sincalide (DB09142)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: C-terminal peptide-modified hGH (MOD-4023) at doses of 0.25, 0.48, or 0.66 mg/kg/wk
Trial: 28233459
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg daily plus vitamin D 60,000 units once weekly
Trial: 26597741
Drug: Aspirin 60
RxNorm normalized name: aspirin 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 60 mg/d
Trial: 31347430
Drug: Aspirin 81
RxNorm normalized name: aspirin 81 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 81 to 200 mg (aspirin group)
Trial: 31347430
Drug: Aspirin 81
RxNorm normalized name: aspirin 81 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 81 to 200 mg plus cilostazol 200 mg (dual group)
Trial: 7936257
Drug: Protocol for
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol for treatment of acute stroke
Trial: 1349485
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg nitrendipine
Trial: 1349485
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg bisoprolol
Trial: 17089419
Drug: Higher weekly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Higher weekly contact hours
Trial: 15209772
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin
Trial: 16931867
Drug: Glucose+fructose solution
RxNorm normalized name: fructose / glucose / phosphoric acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose+fructose solution
Trial: 1020902
Drug: 5 000
RxNorm normalized name: penicillin G
DrugBank: Benzylpenicillin (DB01053)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5 000 units of heparin preoperatively and every 12 hours following the operation
Trial: 31630117
Drug: Programmed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Programmed treatment group
Trial: 27469171
Drug: Tapered interference
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapered interference fit (TIF) implants
Trial: 1691243
Drug: Combination therapies
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapies targeting different viral replicative sites
Trial: 25582816
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment (levofloxacin 500 mg daily and ibuprofen 200 mg twice a day for 6 weeks)
Trial: 28043731
Drug: Acetazolamide (250mg)
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetazolamide (250mg) and Hydrochlorothiazide (50mg) daily
Trial: 28043731
Drug: Furosemide (40mg)
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide (40mg) and Hydrochlorothiazide (50mg) daily
Trial: 22292366
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine group (WM group)
Trial: 7530680
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy with bleomycin, etoposide, and cisplatin
Trial: 7957521
Drug: Oral colchicine
RxNorm normalized name: Colchicine
DrugBank: Colchicine (DB01394)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral colchicine 1 mg (healthy volunteers)
Trial: 7957521
Drug: Oral colchicine
RxNorm normalized name: Colchicine
DrugBank: Colchicine (DB01394)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral colchicine 1 mg (elderly subjects)
Trial: 8523876
Drug: Low-dose aprotinin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose aprotinin protocol
Trial: 27065001
Drug: Eplerenone 25
RxNorm normalized name: eplerenone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 25 mg once daily (up-titrated to 50 mg/day after 4 weeks)
Trial: 10439688
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (n = 80)
Trial: 22095569
Drug: Mass azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mass azithromycin distributions (3 annual treatments)
Trial: 18847313
Drug: G-CSF alone
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF alone
Trial: 6364329
Drug: 2000 mg
RxNorm normalized name: bran 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 mg metronidazole as a single dose on the first and third days
Trial: 11030499
Drug: Stretching intervention
RxNorm normalized name: Mederma Stretch Mark Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stretching intervention (30 minutes of daily stretching into dorsiflexion with a torque of 7.5 N x m for 4 weeks)
Trial: 14713918
Drug: Cetirizine 10
RxNorm normalized name: cetirizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 10 mg daily and zafirlukast 20 mg twice a day
Trial: 9209776
Drug: Sumatriptan 5
RxNorm normalized name: sumatriptan 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan 5 mg
Trial: 2182350
Drug: Daily-wear hard
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily-wear hard (DWH) PMMA contact lens
Trial: 43950
Drug: 40 or
RxNorm normalized name: Azor 5/40 Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 or 100 mg betadrenol
Trial: 17174226
Drug: Soybean oil
RxNorm normalized name: Soybean Oil
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soybean oil (60 mL, fresh and deep-fried)
Trial: 25381189
Drug: Reiki therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reiki therapy
Trial: 7872895
Drug: Cisplatin followed
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin followed by 120-hr continuous 5-FU infusion (Group A)